Quetiapine in Specific Phobia

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Specific Phobia
Interventions
DRUG

Quetiapine XR

100 mg single-dose Quetiapine XR

OTHER

Placebo

Placebo

Trial Locations (1)

48149

University Hospital Muenster, Department of Psychiatry, Münster

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University Hospital Muenster

OTHER